What is it about?

Despite observational studies suggesting that COPD exacerbation can be detected using a combination of symptoms and physiological measures, larger randomized controlled trials have not shown any effect of telemonitoring on time to first hospital admission (TTFH), hospitalization and quality of life. This randomized controlled trial of 312 COPD patients is the first using only objective lung function data measured daily by the forced oscillation technique to prompt early intervention. This approach did not affect TTFH and quality of life, however, it significantly reduced healthcare costs, mostly due to a reduction in duration and frequency of subsequent hospitalisations.

Featured Image

Read the Original

This page is a summary of: Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial, American Review of Respiratory Disease, September 2018, American Thoracic Society,
DOI: 10.1164/rccm.201712-2404oc.
You can read the full text:

Read

Contributors

The following have contributed to this page